The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, healthy aging, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a nonpartisan foundation focused on improving the health of communities and entire populations.
June 15, 2022
Multipayer Primary Care Network Primary Care Transformation Primary Care Spending Targets
Jun 9, 2022
Mar 10, 2022
Jan 18, 2022
Back to Articles and Updates
The COVID-19 pandemic highlighted the critical role that primary care plays in guarding the health and well-being of all people. As a result, an increasing number of state legislatures and administrations have taken action to enhance financial support for these essential services. More states are using legislative and regulatory authority to measure or report on primary care spending and, in some cases, to set targets for increasing investment in primary care.
On June 22, 2022, the Milbank Memorial Fund, the Primary Care Collaborative, and the American Academy of Family Physicians hosted a webinar, which reviewed state activity and dove into the experiences of the general assemblies in Maryland and Maine with the teams that made it happen in their home states.
View a recording
Download the slides
Get the Latest from the Milbank Memorial Fund
An endowed operating foundation that engages in nonpartisan analysis, collaboration, and communication, with an emphasis on state health policy.